Executive

Porton Pharma Solutions Enters the Nordic Region

Even if Porton Pharma Solutions is one of the major CDMO players worldwide, it still takes a lot of work to enter a completely new market. However, with a robust plan for investment and growth, the company is confident that an established presence in the Nordic region is on the horizon.
Henrik Malmgreen

From its inception in 2005 as a small molecule-focused contract manufacturing organization (CMO) based out of Chongqing in China, Porton Pharma Solutions has grown into a global end-to-end contract manufacturing and development organization (CDMO) that aims to serve customers all around the world. Over the coming years, the company aims to establish a presence in the Nordic market.

In order to get a stronghold, Porton is currently in the process of establishing a manufacturing facility in Slovenia, which will also serve the European market in general. This plant is planned to be fully operational by early 2024. Additionally, the company plans on working with key organizations in the region to better understand customer needs and provide tailored services.

A lot of work is waiting
“Though Porton Pharma Solutions is a well-known and established brand in the Asia Pacific region and developing in North America, there is still a lot of work to be done in the Nordic region. A global perspective is critical to success in the CDMO space, and Porton recognizes this. We are taking initiatives to ensure that we are able to provide robust and customer-focused services globally and have experienced quite a rapid growth within North America”, says Arsalan Khan, Associate Director of Marketing. He continues:

“The aim will be the same for the Nordic region, and through strategic partnerships and investment in facilities like the site in Slovenia, we are excited to see a similar kind of growth when we enter the Nordic region. Establishing yourself in a new market is never easy, but we embrace the challenge and look forward to working with new contacts and customers in the region”.

The Nordic market shows a prospective growth potential, so we have to be very active and ensure that we work with customers to ensure that their needs are addressed”

says Alexandra Pichard Nielsen Vice President of Business Development.

Learn to know the customers
With more than 5.000 customer centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable, and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics. The company’s vision is to be the most open, innovative, and reliable pharmaceutical service platform in the world, and the mission is to enable the public’s early access to good medicines.

“We strive to be as customer centric as possible, and in the nearest future, we will use a lot of resources to establish and maintain a solid network in the Nordic Life Science industry in order to make ourselves well known among key customers in the region. The Nordic market shows a prospective growth potential, so we have to be very active and ensure that we work with customers to ensure that their needs are addressed.

Porton has become a name that resonates with both strong technical expertise as well as high quality customer service, and we intend on bringing this to the region as well”, says Porton’s Vice President of Business Development, Alexandra Pichard Nielsen. 

The Nordic stronghold
For now, it is the office in Copenhagen, Denmark, that is the base of Porton’s operations within the Nordic market, but there is a plan to grow over time and to also be represented in the other Nordic countries. Right now, Porton Pharma Solutions is working on analyzing the new market, which takes place out of the headquarters in China. From there, the aim will be finding outlets for showcasing Porton capabilities and collaborating with customers, as well as nurturing those relationships into projects and revenue.

“The site in Slovenia is a major step in the right direction since it will bring manufacturing capability locally to customers in the area. We are starting to see the growth of some really great relationships with clients already through some of our efforts, and the future looks very bright,” ends Arsalan Khan.

We are taking initiatives to ensure that we are able to provide robust and customer-focused services globally and have experienced quite a rapid growth within North America. The aim will be the same for the Nordic region”

says Arsalan Khan, Associate Director of Marketing.

Porton Pharma Solutions
Porton Pharma Solutions Ltd (Porton) is a contract development and manufacturing organization (CDMO) that provides small molecule APIs (active pharmaceutical ingredients), dosage forms, and biologics manufacturing services. The company offers API process development, manufacturing, technology platform, quality studies and analytical research and development, and CMC registration support services. It also provides drug product CDMO services, biologics CDMO services, client-oriented program management services, among others. Porton operates research and development centers in China, manufacturing facilities in China and process technology centers in the US. The company also has sales offices across Switzerland, Belgium, Denmark, and the US. Porton is headquartered in Chongqing, China.

Scroll til toppen

We use cookies to give you the best experience. By using our site, you accept the use of cookies.